Texas Attorney General Takes on Pharma Again

Start
Texas Attorney General, Ken Paxton, is after pharma once again—invoking a very familiar theory. Last month, in a suit almost identical to the suit filed against Eli Lilly last year, Paxton filed suit against Sanofi-Aventis US LLC (“Sanofi”) in state court for Sanofi’s alleged kickbacks to providers in violation of the Texas Health Care Program Fraud Prevention Act (“THFPA”)….
By: Sheppard, Mullin, Richter & Hampton LLP
Previous Story

How AI Is Revolutionizing Product Safety: Essential Insights for Navigating Risks, Recalls, and Regulations

Next Story

The 6 Pillars of the Trump Administration’s ‘Cyber Strategy for America’: The Devil Will Be in the Details